查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1485750

RNA 干擾技術市場，依類型、應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

RNA Interference Technology Market, By Type, By Application, By End-Users, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 379 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年RNA干擾技術市場規模為15.4562億美元，2024年至2032年複合年成長率為16.5%。

RNA干擾技術市場-市場動態

RNA 干擾技術在推進精準醫學中的作用

RNA 干擾 (RNAi) 技術透過提供個人化治療方案，在推進精準醫療方面發揮關鍵作用。例如，美國國立衛生研究院 (NIH) 的研究人員利用 RNAi 來靶向與癌症相關的特定基因，在腫瘤抑制和個人化治療方法方面展示了有希望的結果。此外，Alnylam Pharmaceuticals 等製藥公司也開發了基於 RNAi 的罕見遺傳性疾病療法，體現了 RNAi 在滿足個別患者需求方面的變革潛力。該技術能夠根據患者特定的基因譜進行精確的基因沉默，促進提高療效並減少副作用的標靶治療的開發，從而徹底改變個人化醫療的格局。

RNA干擾技術市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 16.5% 左右的複合年成長率成長

根據類型區隔，預計 siRNA 將在 2023 年顯示最大的市場佔有率

從應用區隔來看，治療類是2023年的主導類型

依地區分類，北美是 2023 年的主要收入來源

RNA干擾技術市場-區隔分析：

全球 RNA 干擾技術市場根據類型、應用、最終用戶和地區進行區隔。

市場依類型分為三類：dsRNA、siRNA 和 miRNA。短干擾RNA (siRNA) 由於其在基因沉默方面的特異性和有效性而擁有最高的偏好，其次是微小RNA (miRNA)，因其在基因表現中的調節作用而聞名。由於脫靶效應和先天免疫反應，雙股 RNA (dsRNA) 較不受歡迎。

市場根據應用分為三類：藥物發現和開發、治療和農作物改良。由於精準醫學和個人化治療中對基於 RNAi 的治療的需求不斷成長，治療學排名最高。藥物發現和開發緊隨其後，利用 RNAi 技術進行標靶驗證和藥物篩選。由於監管課題和市場複雜性，農作物改良和其他應用的偏好較低。

RNA干擾技術市場-地理洞察

北美，特別是美國，在 Alnylam Pharmaceuticals 和 Arrowhead Pharmaceuticals 等主要參與者的支持下，在生物技術和製藥領域開展了強勁的研發活動，從而引領市場。在歐洲，德國、英國和瑞士等國家在學術與產業合作的支持下，透過強大的生物醫學研究和臨床應用來推動採用。在中國、日本和印度等國家不斷增加的醫療支出、生物技術研究投資以及政府對基因組醫學的支持的推動下，亞太地區呈現快速成長。拉丁美洲提供了對精準醫學和基因療法的關注而帶來的機遇，改善的醫療基礎設施和監管發展有助於市場擴張。在醫療基礎設施投資和個人化醫療意識不斷提高的支持下，中東和非洲也出現了成長，合作加強了該地區的技術轉移和市場發展。

RNA干擾技術市場-競爭格局：

Alnylam Pharmaceuticals、Arrowhead Pharmaceuticals、Dicerna Pharmaceuticals、Quark Pharmaceuticals 和 Silence Therapeutics 等幾家主要參與者都在推動基於 RNAi 的療法的創新和產品開發。 Alnylam Pharmaceuticals 因其專注於罕見遺傳疾病而脫穎而出，而 Arrowhead Pharmaceuticals 則專注於基於 RNAi 的肝病和癌症藥物。著名的合作實例包括 Alnylam Pharmaceuticals 與 Regeneron Pharmaceuticals 合作，利用 Alnylam 在 RNAi 治療方面的專業知識和 Regeneron 在抗體技術方面的能力，開發基於 RNAi 的眼部和中樞神經系統疾病治療方法。 Dicerna Pharmaceuticals 利用其專有的 RNAi 技術平台來治療各種疾病途徑，而 Quark Pharmaceuticals 則專注於眼部疾病和腎臟損傷。 Silence Therapeutics 利用先進的遞送系統開發針對心血管疾病、癌症和罕見遺傳性疾病的 RNAi 療法。這些公司在技術進步、治療管道以及與學術和製藥合作夥伴的策略合作方面展開競爭，反映了動態的市場格局，正在進行的研究和臨床試驗旨在證明基於 RNAi 的療法的有效性和安全性。

最近的發展：

2024 年 4 月，Medison Pharma 和 Alnylam Pharmaceuticals, Inc. 宣布進一步擴大其在中歐、東歐和以色列的現有合作夥伴關係，以在包括澳洲在內的其他拉丁美洲和亞太市場將 RNAi 療法商業化。

2023 年 6 月，加拿大害蟲管理研究機構批准了一項 RNAi 生物農藥輸送技術的實地研究，這是一種保護農作物免受昆蟲侵害的環保方式。

目錄

第 1 章：RNA 干擾技術市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 依類型分類的 RNA 干擾技術市場片段
    • RNA 干擾技術市場片段（依應用）
    • 最終用戶的 RNA 干擾技術市場片段
    • 依國家/地區分類的 RNA 干擾技術市場片段
    • 依地區分類的 RNA 干擾技術市場片段
  • 競爭洞察

第 3 章：RNA 干擾技術主要市場趨勢

  • RNA干擾技術市場促進因素
    • 市場促進因素的影響分析
  • RNA干擾技術市場限制
    • 市場限制影響分析
  • RNA干擾技術的市場機會
  • RNA干擾技術市場未來趨勢

第 4 章：RNA 干擾技術產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：RNA 干擾技術市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：RNA 干擾技術市場模式

  • 2023 年 RNA 干擾技術市佔分析
  • 依主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：RNA 干擾技術市場 - 依類型

  • 概述
    • 依類型分類的區隔市場佔有率分析
    • 雙股RNA
    • siRNA
    • miRNA

第 8 章：RNA 干擾技術市場 - 依應用

  • 概述
    • 依應用分類的區隔市場佔有率分析
    • 藥物發現與開發
    • 療法
    • 農作物改良
    • 其他

第 9 章：RNA 干擾技術市場 - 由最終用戶

  • 概述
    • 依最終用戶分類的區隔市場佔有率分析
    • 製藥公司
    • 生技公司
    • 合約研究組織
    • 學術界
    • 研究中心
    • 其他

第 10 章：RNA 干擾技術市場 - 依地理位置

  • 介紹
    • 依地理位置分類的區隔市場佔有率分析
  • 北美洲
    • 概述
    • RNA干擾技術北美主要廠商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（依類型）
    • 北美市場規模和預測（依應用）
    • 北美市場規模和預測（依最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲RNA干擾技術主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模與預測（依類型）
    • 歐洲市場規模和預測（依應用）
    • 歐洲市場規模和預測（依最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太區RNA干擾技術主要廠商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模與預測（依類型）
    • 亞太地區市場規模與預測（依應用）
    • 亞太地區最終用戶市場規模與預測
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲RNA干擾技術主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模與預測（依類型）
    • 拉丁美洲市場規模與預測（依應用）
    • 拉丁美洲市場規模和預測（依最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲RNA干擾技術主要生產商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依類型）
    • 中東和非洲市場規模及預測（依應用）
    • 中東和非洲市場規模和預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第11章：RNA干擾技術產業主要供應商分析

  • 競爭儀表板
  • 公司簡介
    • Alnylam Pharmaceuticals, Inc.
    • Arbutus Biopharma Corporation
    • Arrowhead Pharmaceuticals, Inc.
    • Benitec Biopharma Limited
    • DicereGen, Inc.
    • Dicerna Pharmaceuticals, Inc.
    • Gradalis, Inc.
    • Ionis Pharmaceuticals, Inc.
    • miRagen Therapeutics, Inc.
    • Quark Pharmaceuticals, Inc.
    • Regulus Therapeutics Inc.
    • RXi Pharmaceuticals Corporation
    • Silence Therapeutics plc
    • Sirnaomics, Inc.
    • Sylentis SAU (PharmaMar Group)
    • Tacere Therapeutics, Inc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2648

REPORT HIGHLIGHT

RNA Interference Technology Market size was valued at USD 1,545.62 Million in 2023, expanding at a CAGR of 16.5% from 2024 to 2032.

The RNA interference (RNAi) technology market involves using small RNA molecules to silence gene expression, with applications in gene therapy, drug discovery, and functional genomics. Increasing demand for precise therapies in personalized medicine, and advancements in drug delivery systems enabling efficient RNAi-based treatments are driving the demand for the market. However, challenges such as off-target effects, and delivery complexities impede market growth. Opportunities exist in applying RNAi to neurodegenerative diseases, forming partnerships for innovative therapies and delivery methods, and entering untapped markets in developing regions with rising healthcare investment and research activity, promising prospects for RNAi technology adoption.

RNA Interference Technology Market- Market Dynamics

RNA Interference Technology's Role in Advancing Precision Medicine

RNA interference (RNAi) technology is pivotal in advancing precision medicine by offering personalized treatment options. For instance, researchers at the National Institutes of Health (NIH) have utilized RNAi to target specific genes implicated in cancer, demonstrating promising results in tumor suppression and personalized therapy approaches. Additionally, pharmaceutical companies like Alnylam Pharmaceuticals have developed RNAi-based therapeutics for rare genetic disorders, exemplifying the transformative potential of RNAi in addressing individual patient needs. This technology enables precise gene silencing tailored to patient-specific genetic profiles, facilitating the development of targeted therapies with enhanced efficacy and reduced side effects, thereby revolutionizing the landscape of personalized medicine.

RNA Interference Technology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.5% over the forecast period (2024-2032)

Based on Type segmentation, siRNA was predicted to show maximum market share in the year 2023

Based on application segmentation, therapeutics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

RNA Interference Technology Market- Segmentation Analysis:

The Global RNA Interference Technology Market is segmented based on Type, Application, End-Users, and Region.

The market is divided into three categories based on Type: dsRNA, siRNA, and miRNA. Short interfering RNA (siRNA) holds the highest preference due to its specificity and effectiveness in gene silencing, followed by microRNA (miRNA), known for its regulatory role in gene expression. Double-stranded RNA (dsRNA) is less favored due to off-target effects and innate immune responses.

The market is divided into three categories based on application: Drug Discovery and Development, Therapeutics, and Agricultural Crop Modifications. Therapeutics ranks highest, driven by increasing demand for RNAi-based treatments in precision medicine and personalized therapies. Drug discovery and development follow closely, leveraging RNAi technology for target validation and drug screening. Agricultural crop modifications and other applications exhibit lower preference due to regulatory challenges and market complexity.

RNA Interference Technology Market- Geographical Insights

North America, particularly the United States, leads the market with robust research and development activities in the biotechnology and pharmaceutical sectors, supported by key players like Alnylam Pharmaceuticals and Arrowhead Pharmaceuticals. In Europe, countries such as Germany, the UK, and Switzerland drive adoption through strong biomedical research and clinical applications, bolstered by academic-industry collaborations. The Asia Pacific region shows rapid growth, driven by increasing healthcare expenditure, biotechnology research investments, and governmental support for genomic medicine in countries like China, Japan, and India. Latin America presents opportunities fueled by the focus on precision medicine and genetic therapies, with improving healthcare infrastructure and regulatory developments aiding market expansion. The Middle East and Africa also see growth, supported by healthcare infrastructure investments and rising awareness about personalized medicine, with collaborations enhancing technology transfer and market development in the region.

RNA Interference Technology Market- Competitive Landscape:

Several key players such as Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Quark Pharmaceuticals, and Silence Therapeutics, all drive innovation and product development in RNAi-based therapeutics. Alnylam Pharmaceuticals stands out for its focus on rare genetic diseases, while Arrowhead Pharmaceuticals specializes in RNAi-based drugs for liver diseases and cancer. Notable instances of collaboration include Alnylam Pharmaceuticals' partnership with Regeneron Pharmaceuticals to develop RNAi-based treatments for ocular and CNS diseases, leveraging Alnylam's expertise in RNAi therapeutics and Regeneron's capabilities in antibody technologies. Dicerna Pharmaceuticals leverages its proprietary RNAi technology platform for various disease pathways, and Quark Pharmaceuticals focuses on ocular diseases and kidney injuries. Silence Therapeutics develops RNAi therapies for cardiovascular diseases, cancer, and rare genetic disorders using advanced delivery systems. These companies compete on technological advancements, therapeutic pipelines, and strategic collaborations with academic and pharmaceutical partners, reflecting a dynamic market landscape with ongoing research and clinical trials to demonstrate the efficacy and safety of RNAi-based therapies.

Recent Developments:

In April 2024, Medison Pharma and Alnylam Pharmaceuticals, Inc. announced a further expansion of their existing partnership in Central & Eastern Europe and Israel, to commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia.

In June 2023, Canada's Pest Management Research Agency approved a field study for RNAi biopesticide delivery technology, which is an eco-friendly way to protect crops from insects.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Alnylam Pharmaceuticals, Inc.

Arbutus Biopharma Corporation

Arrowhead Pharmaceuticals, Inc.

Benitec Biopharma Limited

DicereGen, Inc.

Dicerna Pharmaceuticals, Inc.

Gradalis, Inc.

Ionis Pharmaceuticals, Inc.

miRagen Therapeutics, Inc.

Quark Pharmaceuticals, Inc.

Regulus Therapeutics Inc.

RXi Pharmaceuticals Corporation

Silence Therapeutics plc

Sirnaomics, Inc.

Sylentis S.A.U. (PharmaMar Group)

Tacere Therapeutics, Inc.

Others

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • dsRNA
  • siRNA
  • miRNA

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Discovery and Development
  • Therapeutics
  • Agricultural Crop Modifications
  • Others

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY END-USERS- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations
  • Academia
  • Research Centers
  • Others

GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.RNA Interference Technology Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.RNA Interference Technology Market Snippet by Type
    • 2.1.2.RNA Interference Technology Market Snippet by Application
    • 2.1.3.RNA Interference Technology Market Snippet by End-Users
    • 2.1.4.RNA Interference Technology Market Snippet by Country
    • 2.1.5.RNA Interference Technology Market Snippet by Region
  • 2.2.Competitive Insights

3.RNA Interference Technology Key Market Trends

  • 3.1.RNA Interference Technology Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.RNA Interference Technology Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.RNA Interference Technology Market Opportunities
  • 3.4.RNA Interference Technology Market Future Trends

4.RNA Interference Technology Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.RNA Interference Technology Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.RNA Interference Technology Market Landscape

  • 6.1.RNA Interference Technology Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.RNA Interference Technology Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.dsRNA
    • 7.1.3.siRNA
    • 7.1.4.miRNA

8.RNA Interference Technology Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Drug Discovery and Development
    • 8.1.3.Therapeutics
    • 8.1.4.Agricultural Crop Modifications
    • 8.1.5.Others

9.RNA Interference Technology Market - By End-Users

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-Users, 2023 & 2032 (%)
    • 9.1.2.Pharmaceutical Companies
    • 9.1.3.Biotechnology Companies
    • 9.1.4.Contract Research Organizations
    • 9.1.5.Academia
    • 9.1.6.Research Centers
    • 9.1.7.Others

10.RNA Interference Technology Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.RNA Interference Technology Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.RNA Interference Technology Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.RNA Interference Technology Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.RNA Interference Technology Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.RNA Interference Technology Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- RNA Interference Technology Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Alnylam Pharmaceuticals, Inc.
    • 11.2.2.Arbutus Biopharma Corporation
    • 11.2.3.Arrowhead Pharmaceuticals, Inc.
    • 11.2.4.Benitec Biopharma Limited
    • 11.2.5.DicereGen, Inc.
    • 11.2.6.Dicerna Pharmaceuticals, Inc.
    • 11.2.7.Gradalis, Inc.
    • 11.2.8.Ionis Pharmaceuticals, Inc.
    • 11.2.9.miRagen Therapeutics, Inc.
    • 11.2.10.Quark Pharmaceuticals, Inc.
    • 11.2.11.Regulus Therapeutics Inc.
    • 11.2.12.RXi Pharmaceuticals Corporation
    • 11.2.13.Silence Therapeutics plc
    • 11.2.14.Sirnaomics, Inc.
    • 11.2.15.Sylentis S.A.U. (PharmaMar Group)
    • 11.2.16.Tacere Therapeutics, Inc.
    • 11.2.17.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE RNA Interference Technology Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global RNA Interference Technology Market, by Type 2019-2032 (USD Million)
  • TABLE RNA Interference Technology Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global RNA Interference Technology Market, by Application 2019-2032 (USD Million)
  • TABLE RNA Interference Technology Market: End-Users Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-Users
  • TABLE Global RNA Interference Technology Market, by End-Users 2019-2032 (USD Million)
  • TABLE RNA Interference Technology Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global RNA Interference Technology Market, by Region 2019-2032 (USD Million)
  • TABLE North America RNA Interference Technology Market, by Country, 2019-2032 (USD Million)
  • TABLE North America RNA Interference Technology Market, by Type, 2019-2032 (USD Million)
  • TABLE North America RNA Interference Technology Market, by Application, 2019-2032 (USD Million)
  • TABLE North America RNA Interference Technology Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Europe RNA Interference Technology Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe RNA Interference Technology Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe RNA Interference Technology Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe RNA Interference Technology Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA Interference Technology Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA Interference Technology Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA Interference Technology Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific RNA Interference Technology Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Latin America RNA Interference Technology Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America RNA Interference Technology Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America RNA Interference Technology Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America RNA Interference Technology Market, by End-Users, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA Interference Technology Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA Interference Technology Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA Interference Technology Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa RNA Interference Technology Market, by End-Users, 2019-2032 (USD Million)